Therapy News and Research

RSS

Yukon, Canadian Cancer Society announce Kordyban Lodge construction

The ground adjacent to the University Hospital of Northern B.C. is no longer a parking lot. Today, the Canadian Cancer Society B.C. and Yukon together with local government representatives and supporters celebrated the start of construction on the Kordyban Lodge by breaking ground.

16 Jul 2011

USC researcher maps human brain that generates empathy

According to a new study from USC, even failing to possess a full complement of limbs will not stop your brain from understanding what it is like for someone else to experience pain in one of them. It may, however, change the way your brain does so.

16 Jul 2011

Viewpoints: Debt dilemma; IPAB intense defense; Minnesota middle-ground

Let's talk for a minute about what Republican leaders are rejecting. President Obama has made it clear that he's willing to sign on to a deficit-reduction deal that consists overwhelmingly of spending cuts, and includes draconian cuts in key social programs, up to and including a rise in the age of Medicare eligibility. These are extraordinary concessions.

16 Jul 2011

Pennsylvania State reminds massage therapists to become licensed before December deadline

The Pennsylvania State Massage Therapy Licensing Board is reminding existing massage therapists of the approaching December deadline to become licensed under the grandfather provision of state law. The board operates under the Department of State.

15 Jul 2011

Ellipse's MAGEC System can effectively treat children with Early Onset Scoliosis

Ellipse Technologies announced today that preliminary clinical data suggests children with Early Onset Scoliosis (EOS) can be treated safely and effectively without the conventional protocol of repeated surgeries to straighten their growing spine.

15 Jul 2011

B. Braun adds Plasmat Futura System to H.E.L.P. LDL Apheresis therapy

The Renal Therapies Division of B. Braun Medical Inc. (B. Braun) announced today the availability of the Plasmat Futura System for H.E.L.P. LDL Apheresis therapy.

From B. Braun Melsungen AG 15 Jul 2011

Study: Bone marrow transplant offers new hope for patients with high-risk leukemia

Bone marrow transplant survival more than doubled in recent years for young, high-risk leukemia patients treated at St. Jude Children's Research Hospital, with patients who lacked genetically matched donors recording the most significant gains. The results are believed to be the best ever reported for leukemia patients who underwent bone marrow transplantation.

15 Jul 2011

IQWiG finds no differences between two treatment strategies for type 2 diabetes

Whether patients with type 2 diabetes mellitus benefit from attempts to lower their blood glucose levels to near-normal levels through treatment remains an unanswered question. The studies currently available provide indications of a benefit but also of potential harm.

15 Jul 2011

Simple steps can improve malaria prevention

Megan Fotheringham, a public health adviser with the President's Malaria Initiative, describes in a post on USAID's "IMPACTblog" how a program in Kenya worked to improve the successful administration of malaria prevention therapy among pregnant women in the country's Gem District simply by sending to antenatal clinics a memo describing when to administer the treatment.

15 Jul 2011

Seattle Children's inaugurates new center for cancer research

Today, Seattle Children's Research Institute announced the opening of the Center for Childhood Cancer Research.

15 Jul 2011

Tocotrienol could help reduce stroke damage

Preventive supplementation with a natural form of vitamin E called tocotrienol could help reduce brain damage caused by strokes, researchers reported today at the 2nd International Conference on Tocotrienols and Chronic Diseases.

15 Jul 2011

UTHealth enrolls first patient in new stem cell therapy trial for ischemic stroke

The first Texas patient has been enrolled by researchers at The University of Texas Health Science Center at Houston in the country's first double-blind clinical trial studying the safety and efficacy of an innovative stem cell therapy that can be given up to 19 days after an ischemic stroke.

15 Jul 2011

ASTRO develops white paper on safe use of intensity modulated radiation therapy

As part of the Target Safely initiative, the American Society for Radiation Oncology (ASTRO) has developed a white paper, the first of a series of such papers, on the safe use of integrating intensity modulated radiation therapy (IMRT) into the radiation oncology clinic.

15 Jul 2011

State roundup: Model insurance brings 'modest' savings

Blue Cross Blue Shield of Massachusetts' alternative quality contract, which Governor Deval Patrick has held up as a potential model for controlling health care costs, produced "modest" savings in its first year while yielding improved quality of care in some areas, according to a new study in this week's New England Journal of Medicine.

15 Jul 2011

Camel blood can help scientists fight against cancer

Nanobodies produced from camel blood have unique properties, which can be used in future drug development. New research published in Journal of Controlled Release confirms that camel blood can help scientists in the fight against cancer.

15 Jul 2011

NeoStem to acquire Amorcyte

NeoStem, Inc., an international biopharmaceutical company, announced the signing of a definitive merger agreement whereby NeoStem will acquire Amorcyte, Inc., a development stage cell therapy company focusing on novel treatments for cardiovascular disease.

15 Jul 2011

Yervoy, a new melanoma drug approved in Australia

Australia has approved the world’s first drug to prolong the lives of people with advanced melanoma. The drug Yervoy received the nod from the Therapeutics Good Association (TGA) on Friday amid hopes it could add two years to the life of people with the deadliest form of skin cancer but for whom other treatments have failed.

14 Jul 2011

FDA grants Novian Health IDE approval for Novilase ILT System to treat breast cancer

Novian Health, developer of Novilase® Breast Therapy, announced that the US Food and Drug Administration (FDA) has granted investigational device exemption (IDE) approval for the company to start a multi-center study of its Novilase® Interstitial Laser Therapy (ILT) System. Novian developed the ILT System for the ablation of small (up to 20 mm) malignant breast tumors.

14 Jul 2011

USPTO awards patent for Convergen LifeSciences' CNVN202 to treat lung cancer

Convergen LifeSciences, Inc. announced today that another United States Patent 7,977,468 has been awarded by the U.S. Patent and Trademark Office jointly to The University of Texas System Board of Regents and The Secretary, U.S. Department of Health and Human Services.

14 Jul 2011

EC grants marketing authorization for BENLYSTA to treat SLE

GlaxoSmithKline and Human Genome Sciences, Inc. announced today that the European Commission has granted marketing authorization for BENLYSTA 10mg/kg as an add-on therapy in adult patients with active autoantibody-positive systemic lupus erythematosus, with a high degree of disease activity, despite standard therapy.

14 Jul 2011